Amiodarone-induced thyrotoxicosis - 25/05/21
Hyperthyroïdies induites par l’amiodarone
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Abstract |
Amiodarone-induced thyrotoxicosis (AIT) are not uncommon endocrinopathies. Clinicians are sometimes faced with difficult diagnostic and therapeutic situations. The disease pathophysiology is partially understood, explaining the lack of predictive factors for occurrence. Different international recommendations for their management have been published: the most recent in 2018 by the European Thyroid Association (ETA) (Ross et al., 2016; Bartalena et al., 2018). The purpose of this paper is to present the essential concepts for their management and to review the literature since 2018.
El texto completo de este artículo está disponible en PDF.Keywords : Amiodarone, Thyrotoxicosis, Hyperthyroidism
Esquema
Vol 82 - N° 3-4
P. 163-166 - juin 2021 Regresar al número
Artículo precedente
- “Is there any reason to treat subclinical hypo and hyperthyroidism?”
- Bernadette Biondi
- Cardiac complications of thyroid hormone resistance syndromes
- Frédéric Illouz, Claire Briet, Delphine Mirebeau-Prunier, Natacha Bouhours-Nouet, Régis Coutant, Paul Sibilia, Patrice Rodien
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.